Cystic fibrosis, a genetic disorder, affects lungs and other organs. It causes thick mucus buildup. Researchers have ...

Non-cystic fibrosis bronchiectasis (NCFB) is a heterogeneous disease characterised by a ‘vicious vortex’ of ...

The HealthWell Foundation®, an independent non-profit charitable organization that provides financial assistance for underinsured Americans, has opened a new fund to assist individuals living with ...

Your hands and nails can offer warning signs of underlying disease and even chronic conditions like arthritis or psoriasis. Dr Sood shares 5 signs.

Bronchiectasis, a chronic respiratory condition, is characterized by irreversible airway dilation, leading to mucus clearance issues, infections, and lung inflammation. The global bronchiectasis ...

The non-cystic fibrosis bronchiectasis treatment market is witnessing vigorous expansion owing to multiple compelling drivers. Firstly, increasing prevalence of pulmonary diseases and growing levels ...

BRIDGEWATER, N.J. - Insmed Incorporated (NASDAQ:INSM) announced Tuesday that the European Commission has approved BRINSUPRI (brensocatib) as the first and only treatment for non-cystic fibrosis ...

— BRINSUPRI Was Reviewed Under EMA's Accelerated Assessment Pathway as It Is Considered of Major Interest for Public Health — BRIDGEWATER, N.J., Nov. 18, 2025 /PRNewswire/ -- Insmed Incorporated ...

— BRINSUPRI Was Reviewed Under EMA's Accelerated Assessment Pathway as It Is Considered of Major Interest for Public Health — NCFB is a chronic and progressive disease that can lead to permanent lung ...